SPINRAZA (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy

Friday, December 23, 2016 1 min read

Key Takeaway: SPINRAZA (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy

Full Press Release Details

SPINRAZA (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy.